申请人:Vertex Pharmaceuticals Incorporated
公开号:US20190119253A1
公开(公告)日:2019-04-25
Crystalline Forms of Compound I:
and pharmaceutically acceptable salts thereofare disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.
化合物I的结晶形式以及其药用盐被披露。同时也披露了包含这些结晶形式的药物组合物、使用这些结晶形式治疗囊性纤维化的方法,以及制备这些结晶形式的方法。